title: The SAFE study: saline vs. albumin for fluid resuscitation in the critically ill.
authors.affiliation: The Australian and New Zealand Intensive Care Society (ANZICS) Clinical Trials Group, Australian Red Cross Blood Service, South Melbourne, Victoria.
authors.forename: S
authors.initials: S
authors.lastname: Finfer
authors.forename: R
authors.initials: R
authors.lastname: Norton
authors.forename: R
authors.initials: R
authors.lastname: Bellomo
authors.forename: N
authors.initials: N
authors.lastname: Boyce
authors.forename: J
authors.initials: J
authors.lastname: French
authors.forename: J
authors.initials: J
authors.lastname: Myburgh
mesh_terms: D000328:Adult; D000368:Aged; D000418:Albumins / Q000627:therapeutic use*; D001315:Australia; D016638:Critical Illness; D005260:Female; D005440:Fluid Therapy / Q000379:methods*; D005500:Follow-Up Studies; D006801:Humans; D007362:Intensive Care Units; D008297:Male; D008875:Middle Aged; D009520:New Zealand; D012306:Risk; D018805:Sepsis / Q000628:therapy; D012965:Sodium Chloride / Q000494:pharmacology / Q000627:therapeutic use*; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D000418:Albumins; D012965:Sodium Chloride